{"organizations": [], "uuid": "e607fe5c476e3f3620ef2d4db977a27527611f4e", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://feeds.reuters.com/reuters/companyNews\r", "section_title": "Reuters: Company News", "url": "https://www.reuters.com/article/brief-chemed-q4-gaap-earnings-per-share/brief-chemed-q4-gaap-earnings-per-share-3-25-idUSASB0C5S5", "country": "US", "domain_rank": 408, "title": "BRIEF-Chemed Q4 GAAP Earnings Per Share $3.25", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-02-14T23:36:00.000+02:00", "replies_count": 0, "uuid": "e607fe5c476e3f3620ef2d4db977a27527611f4e"}, "author": "", "url": "https://www.reuters.com/article/brief-chemed-q4-gaap-earnings-per-share/brief-chemed-q4-gaap-earnings-per-share-3-25-idUSASB0C5S5", "ord_in_thread": 0, "title": "BRIEF-Chemed Q4 GAAP Earnings Per Share $3.25", "locations": [], "entities": {"persons": [{"name": "vitas", "sentiment": "none"}], "locations": [], "organizations": [{"name": "reuters", "sentiment": "negative"}, {"name": "chemed corp", "sentiment": "none"}, {"name": "chemed", "sentiment": "none"}, {"name": "thomson reuters", "sentiment": "none"}, {"name": "vitas", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": " 37 PM / in 6 minutes BRIEF-Chemed Q4 GAAP Earnings Per Share $3.25 Reuters Staff Feb 14 (Reuters) - Chemed Corp: * CHEMED REPORTS FOURTH-QUARTER 2017 RESULTS * Q4 ADJUSTED EARNINGS PER SHARE $2.32 * Q4 GAAP EARNINGS PER SHARE $3.25 * Q4 REVENUE ROSE 6.2 PERCENT TO $428 MILLION * SEES FY 2018 ADJUSTED EARNINGS PER SHARE $10.60 TO $10.85 EXCLUDING ITEMS * SAYS NET REVENUE FOR VITAS WAS $292 MILLION IN Q4 OF 2017, WHICH IS AN INCREASE OF 2.8% * REVENUE GROWTH FOR VITAS IN 2018, PRIOR TO MEDICARE CAP, IS ESTIMATED TO BE IN THE RANGE OF 2.5% TO 3.5%‍​ * SAYS FULL-YEAR 2018 ADJUSTED EARNINGS PER DILUTED SHARE, ESTIMATED TO BE IN RANGE OF $10.60 TO $10.85 * ADMISSIONS AND AVERAGE DAILY CENSUS IN 2018 FOR VISTAS ARE ESTIMATED TO EXPAND APPROXIMATELY 3% TO 4% ‍​ * ROTO-ROOTER IS FORECASTED TO ACHIEVE FULL-YEAR 2018 REVENUE GROWTH OF 4.0% TO 5.0%‍​ * Q4 EARNINGS PER SHARE VIEW $2.27, REVENUE VIEW $423.8 MILLION -- THOMSON REUTERS I/B/E/S * ADJUSTED EBITDA MARGIN FOR ROTO-ROOTER FOR 2018 IS ESTIMATED AT 22.3%‍​ * FY2018 EARNINGS PER SHARE VIEW $10.01 -- THOMSON REUTERS I/B/E/S Source text for Eikon: Further company coverage:", "external_links": [], "published": "2018-02-14T23:36:00.000+02:00", "crawled": "2018-02-14T23:50:25.121+02:00", "highlightTitle": ""}